Lau DH - Search Results

1

Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.

Lau DH, Lewis AD, Ehsan MN, Sikic BI. Lau DH, et al. Cancer Res. 1991 Oct 1;51(19):5181-7. Cancer Res. 1991. PMID: 1717140

2

Characterization of covalent DNA binding of morpholino and cyanomorpholino derivatives of doxorubicin.

Lau DH, Durán GE, Sikic BI. Lau DH, et al. J Natl Cancer Inst. 1992 Oct 21;84(20):1587-92. doi: 10.1093/jnci/84.20.1587. J Natl Cancer Inst. 1992. PMID: 1404452

3

Sensitization of drug resistant human ovarian cancer cells to cyanomorpholino doxorubicin (MRA-CN) by modulation of glutathione metabolism.

Lewis AD, Durán GE, Lau DH, Sikic BI. Lewis AD, et al. Among authors: lau dh. Int J Radiat Oncol Biol Phys. 1992;22(4):821-4. doi: 10.1016/0360-3016(92)90532-m. Int J Radiat Oncol Biol Phys. 1992. PMID: 1544857

4

Role of cytochrome P-450 from the human CYP3A gene family in the potentiation of morpholino doxorubicin by human liver microsomes.

Lewis AD, Lau DH, Durán GE, Wolf CR, Sikic BI. Lewis AD, et al. Among authors: lau dh. Cancer Res. 1992 Aug 15;52(16):4379-84. Cancer Res. 1992. PMID: 1643634

5

Paradoxical increase in DNA cross-linking in a human ovarian carcinoma cell line resistant to cyanomorpholino doxorubicin.

Lau DH, Ross KL, Sikic BI. Lau DH, et al. Cancer Res. 1990 Jul 1;50(13):4056-60. Cancer Res. 1990. PMID: 2162251

6

Association of DNA cross-linking with potentiation of the morpholino derivative of doxorubicin by human liver microsomes.

Lau DH, Lewis AD, Sikic BI. Lau DH, et al. J Natl Cancer Inst. 1989 Jul 5;81(13):1034-8. doi: 10.1093/jnci/81.13.1034. J Natl Cancer Inst. 1989. PMID: 2733045

7

Metabolic conversion of methoxymorpholinyl doxorubicin: from a DNA strand breaker to a DNA cross-linker.

Lau DH, Duran GE, Lewis AD, Sikic BI. Lau DH, et al. Br J Cancer. 1994 Jul;70(1):79-84. doi: 10.1038/bjc.1994.253. Br J Cancer. 1994. PMID: 8018545 Free PMC article.

8

Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analogues.

Duran GE, Lau DH, Lewis AD, Kühl JS, Bämmler TK, Sikic BI. Duran GE, et al. Among authors: lau dh. Cancer Chemother Pharmacol. 1996;38(3):210-6. doi: 10.1007/s002800050473. Cancer Chemother Pharmacol. 1996. PMID: 8646794

9

Analysis of intracellular retention of morpholinyl anthracyclines in multidrug-resistant cancer-cells by interactive laser cytometry.

Lau D, Duran G, Sikic B. Lau D, et al. Int J Oncol. 1994 Dec;5(6):1273-7. doi: 10.3892/ijo.5.6.1273. Int J Oncol. 1994. PMID: 21559709

10

Sudden arrhythmic death in patients with syncope and implantable cardiac monitor.

Cabanas Grandío P, Pierre B, Bisignani G, Cuneo A, Papp R, Schrader J, Lau DH. Cabanas Grandío P, et al. Among authors: lau dh. Heart Rhythm O2. 2024 Sep 13;5(11):821-824. doi: 10.1016/j.hroo.2024.09.002. eCollection 2024 Nov. Heart Rhythm O2. 2024. PMID: 39651448 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

401 results

Search Page

Filters